Pharmaceutical Supply – Dexamethasone Sodium Phosphate

The contract involves supplying six 30mL vials of Dexamethasone Sodium Phosphate, USP at a concentration of 4mg/mL, specifically for delivery to a U.S. Navy vessel stationed overseas, indicating the need for timely and precise pharmaceutical delivery in a military operational context. This subcontract falls under the pharmaceutical supply category managed by the Medical Supply Chain Pharmaceutical Field Support Activity within the Department of Defense. The procurement process began with the announcement on May 27, 2026, with responses due by June 2, 2026, reflecting a short response window likely due to the urgency of the medical supply. The contract is designated under NAICS code 325412, which corresponds to pharmaceutical preparation manufacturing. The place of performance is identified as FPO (Fleet Post Office) with the specific zip code 09579, aligning it with military mail services for overseas delivery. Although no specific set-aside type or organization type is noted, the contract is positioned to ensure critical pharmaceutical support to deployed military personnel.